Forian Inc. (NASDAQ:FORA) Q4 2022 Earnings Conference Call March 27, 2023 4:30 PM ET Company Participants Max Wygod - Executive Chairman and Interim Chief Executive Officer Michael Vesey - Chief Financial Officer Conference Call Participants Eric Martinuzzi - Lake Street Capital Markets Operator Greetings, and welcome to Forian Inc. Fourth Quarter and Full Year 2022 Financial Results Conference Call and Webcast. At this time, all participants are in a listen-only mode. A question-and-answer session will fol ...

Forian Inc. (NASDAQ:FORA) Q3 2022 Earnings Conference Call November 14, 2022 4:30 PM ET Company Participants Max Wygod - Co-Founder and Executive Chair Daniel Barton - Chief Executive Officer Michael Vesey - Chief Financial Officer Conference Call Participants Eric Martinuzzi - Lake Street Capital Operator Greetings, and welcome to Forian Inc. Third Quarter 2022 Financial Results Conference Call and Webcast. At this time all participants are in a listen-only mode. A question-and-answer session will follow t ...

For the quarter ended September 30, 2022 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-40146 FORIAN INC. (Exact name of registrant as specified in its charter) Delaware 85-3467693 (State of Other Jurisdiction of incorporation or Organization) (I.R.S. Employer Iden ...

Forian Inc. (NASDAQ:FORA) Q2 2022 Earnings Conference Call August 11, 2022 4:30 PM ET Company Participants Max Wygod - Co-Founder and Executive Chair Daniel Barton - Chief Executive Officer Mick Vesey - Chief Financial Officer Conference Call Participants Eric Martinuzzi - Lake Street Scott Fortune - ROTH Capital Partners Operator Greetings, and welcome to Forian Inc. Second Quarter 2022 Financial Results Conference Call and Webcast. At this time all participants are in a listen-only mode. A question-and-a ...

营收数据变化 - 2022年第二季度营收653.4258万美元，较2021年同期的454.7985万美元增加198.6273万美元，主要因医疗信息产品收入增加222.0402万美元（161%）[167][169] - 2022年上半年营收1292.5537万美元，较2021年同期的616.8594万美元增加675.6943万美元，主要源于医疗信息产品销售增加518.1427万美元[167][174] - 2022年上半年收入为12925537美元，较2021年同期调整后收入增加4748031美元[193][197] 营收成本变化 - 2022年第二季度营收成本174.6808万美元，较2021年同期的123.279万美元增加51.4018万美元，因信息产品成本和软件订阅支持成本增加[167][170] - 2022年上半年营收成本331.4357万美元，较2021年同期的169.0676万美元增加162.3681万美元，因软件订阅产品支持成本和信息产品销售增加[167][175] 研发费用变化 - 2022年第二季度研发费用338.7053万美元，较2021年同期的194.9926万美元增加143.7127万美元，因人员、分包劳动力、数据许可和处理费用增加[167][171] - 2022年上半年研发费用660.9924万美元，较2021年同期的344.7764万美元增加316.216万美元，因新产品开发相关费用增加[167][177] 销售和营销费用变化 - 2022年第二季度销售和营销费用151.8669万美元，较2021年同期的117.7035万美元增加34.1634万美元，因产品扩展相关的薪资、佣金和费用增加[167][172] - 2022年上半年销售和营销费用292.9983万美元，较2021年同期的177.601万美元增加115.3973万美元，因产品扩展相关的薪资、佣金和咨询费用增加[167][178] 分离费用情况 - 2022年上半年分离费用561.1857万美元，包括子公司开发活动转移的遣散费19.4814万美元和两名顾问股票期权持续归属费用541.7043万美元[180] - 2022年3月产生分离费用194814美元，记录股票补偿费用5417043美元[191] 资产出售情况 - 2022年3月3日出售安全监控服务相关资产，获得22.5575万美元，产生20.2159万美元收益[181] - 2022年3月3日出售安全监控服务相关资产获225575美元，收益202159美元[191] 交易相关费用变化 - 2022年上半年交易相关费用为0美元，较2021年上半年的1210279美元减少1210279美元[182] 票据发行情况 - 2021年9月1日发行的2400万美元票据，年利率3.5%，2025年9月1日到期[188] 普通股发行及筹资情况 - 2021年4月12日发行1191743股普通股，总收益1200万美元[198] - 2021年9月1日出售可转换本票筹集2400万美元[198] 公司流动性情况 - 截至2022年6月30日，公司主要流动性来源为现金和有价证券，总计23891155美元[198] 调整后EBITDA变化 - 2022年第二季度调整后EBITDA亏损3222235美元，较2021年同期减少415680美元[193][194] - 2022年上半年调整后EBITDA亏损6633603美元，较2021年同期增加143662美元[193][195] 现金流量变化 - 2022年上半年经营活动净现金使用量为564.89万美元，较2021年的817.82万美元减少252.93万美元[199][200] - 2022年上半年投资活动净现金使用量为63.44万美元，较2021年的1.83万美元增加61.61万美元[199][201] - 2022年上半年融资活动净现金使用量为7.12万美元，较2021年的1229.44万美元减少1236.56万美元[199][203] - 2022年上半年现金及现金等价物净减少635.45万美元，2021年上半年净增加409.79万美元[199] 无形资产摊销情况 - 无形资产（除商誉外）按直线法在2 - 8年的估计使用寿命内摊销[206] 商誉减值测试情况 - 商誉每年进行减值测试，或在特定情况下更频繁测试，最近年度评估无减值迹象[207][208] - 测试商誉减值时，定性评估存在减值可能性超50%时进行定量评估[208] 会计准则影响情况 - FASB于2021年10月发布的ASU 2021 - 08，2022年12月15日后生效，预计对合并财务报表无重大影响[210] 新兴成长公司相关情况 - 公司作为“新兴成长公司”，利用JOBS法案的过渡期实施新会计准则[212] - “新兴成长公司”在特定条件下可豁免部分报告要求，豁免至业务合并五周年或不再符合条件[213]

| --- | --- | --- | --- | --- | --- | --- | |-------|-------|----------------------------------------------------|-------|--------------|---------------------------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | May 12, 2022 | Q1 2022 Financial Results | | | | | | | | | | | | | © 2022 Forian Inc. \| Confidential and Proprietary | | 1 | | | Cautionary Statement Regarding Forward-Looking Statements This presentation contains "forward-looking statements" with ...

Forian Inc. (NASDAQ:FORA) Q1 2022 Earnings Conference Call May 12, 2022 4:30 PM ET Company Participants Max Wygod - Co-founder and Executive Chair Daniel Barton - Chief Executive Officer Michael Vesey - Chief Financial Officer Conference Call Participants Eric Martinuzzi - Lake Street Operator Good day and welcome to Forian Inc. First Quarter 2022 Financial Results Conference Call and webcast. At this time all participants are in listen only mode. A question-and-answer session will follow the formal comment ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-40146 FORIAN INC. (Exact name of registrant as specified in its charter) Delaware 85-3467693 (State of Other Jurisdiction of incorporation or Organization) (I.R.S. Employer Identifi ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-40146 FORIAN INC. (Exact name of registrant as specified in its charter) Delaware 85-3467693 (State of Other Jurisdiction of incorporation or Organization) (I.R.S. Employer Iden ...

Forian Inc. (NASDAQ:FORA) Q4 2021 Earnings Conference Call March 24, 2022 4:30 PM ET Company Participants Max Wygod – Co-founder and Executive Chair Dan Barton – Chief Executive Officer Mike Vesey – Chief Financial Officer Conference Call Participants Max Wygod Good afternoon everyone and thank you for joining us today. Forian delivered a strong fourth quarter as we ended an eventful year. We created a strong momentum in our healthcare information segment, evidenced by our revenue growth in 2021 and our ini ...